Boston, MA -- (SBWIRE) -- 10/05/2016 -- Breast cancer is characterized by the malignancy of cells in the tissues of the breast. HER-2 breast cancer is the most common type of breast cancer. The HER-2 protein, present on the surface of normal breast cells, affects the growth of the malignant cells. The uncontrolled synthesis of this protein stimulates the growth and division of malignant cells. Antibodies are the proteins produced by B-cells (in the bone marrow) in the immune system. These proteins attach themselves to antigens, which act as markers, and are then destroyed by phagocytes. B-cells produce different antibodies, which attach themselves to different sites of an antigen. mAbs are monospecific, as they are the clones of a single parent cell.

Get More Details on this Report and a Full Table of Contents at Global Breast Cancer Monoclonal Antibodies Market 2016-2020

Technavio's analysts forecast the global breast cancer monoclonal antibodies (mAbs) market to post a revenue of 13.7 billion by 2020.

Covered in this report
The report covers the present scenario and the growth prospects of the global breast cancer monoclonal antibodies (mAbs) market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sale of branded mAbs and biosimilars used to treat breast cancer.

The market is divided into the following segments based on geography:

-Americas
-APAC
-EMEA

Technavio's report, Global Breast Cancer Monoclonal Antibodies (mAbs) Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

-Amgen
-Roche
-Mylan

Other prominent vendors

-Array BioPharma
-AstraZeneca
-Biocad
-Boehringer Ingelheim
-Bristol-Myers Squibb
-Celldex Therapeutics
-Celltrion
-Chugai Pharmaceutical
-Daiichi Sankyo
-DARA Biosciences
-Eddingpharm
-Eisai
-Galena Biopharma
-GlaxoSmithKline
-Halozyme Therapeutics
-Hospira
-ImmunoGen
-Immunomedics
-MacroGenics
-Merck
-Novartis
-Oncothyreon
-Pfizer
-ProStrakan
-Puma Biotechnology
-Seattle Genetics
-Sun Pharmaceutical Industries
-Synta Pharmaceuticals
-Teva Pharmaceuticals

Market driver

-Reimbursement benefits for breast cancer mAbs
-For a full, detailed list, view our report

Market challenge

-Absence of adequate diagnosis and screening procedures for early detection
-For a full, detailed list, view our report

Market trend

-Emergence of targeted and combination therapies for breast cancer
-For a full, detailed list, view our report

Key questions answered in this report

-What will the market size be in 2020 and what will the growth rate be?
-What are the key market trends?
-What is driving this market?
-What are the challenges to market growth?
-Who are the key vendors in this market space?
-What are the market opportunities and threats faced by the key vendors?
-What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Companies Mentioned in this Report: Roche, Amgen, Mylan, Actavis, Array BioPharma, AstraZeneca, Biocad, Boehringer Ingelheim, Bristol-Myers Squibb, Celldex Therapeutics, Celltrion, Chugai Pharmaceutical, Daiichi Sankyo, DARA Biosciences, Eddingpharm, Eisai, Galena Biopharma, GlaxoSmithKline, Halozyme Therapeutics, Hospira, ImmunoGen, Immunomedics, MacroGenics, Merck, Novartis, Oncothyreon, Pfizer, ProStrakan, Puma Biotechnology, Seattle Genetics, Sun Pharmaceutical Industriesf, Synta Pharmaceuticals, Teva Pharmaceuticals.

About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Pharmaceuticals research reports at Fast Market Research

You may also be interested in these related reports:
-Global Cancer Immunotherapies Market 2016-2020
-Global Cancer Monoclonal Antibody Partnering Terms and Agreements 2010-2016: Deal trends, players and financials
-Breast Cancer Therapeutics in Major Developed Markets to 2021 - Growth Driven by Rapid Uptake of Premium Priced Biologics and Rising Incidence
-Breast Cancer Therapeutics in Asia-Pacific Markets to 2021 - Growth Driven by Increasing Uptake of Premium Priced Biologics and Rising Prevalence
-Metastatic Breast Cancer Global Clinical Trials Review, H2, 2016